Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2008

View Archived Issues

1018-ISS safely combined with irinotecan-cetuximab in colorectal cancer

Study finds endoscopic ultrasound-guided delivery of BrachySil safe

Cel-Sci provides Multikine update

Avastin receives broad label extension in Europe for metastatic colorectal cancer

NPS provides update on Gattex in short bowel syndrome

Quest and BC Cancer Agency to develop photodynamic therapies for lung cancer

Sepracor acquires exclusive U.S. rights to ciclesonide

Novel therapeutic agents for infections disclosed in recent patent literature

Surface Logix achieves objectives with SLx-4090 in phase IIa trial

Velcura to initiate clinical trials following successful IND application to FDA

Bone Medical's rheumatoid arthritis drug BN-006 inhibits both IL-6 and TNF secretion

Recent AstraZeneca and GSK patents describe novel diagnostic agents

New treatments for gastrointestinal disorders reported in recent GSK and Anadys patents

Positive preclinical data on sustained-release prostacyclin analogue in PH

New HIV integrase inhibitor developed at Merck Research Laboratories

FDA grants IND clearance to Tranzyme for oral ghrelin agonist TZP-102 for gastroparesis

Lpath humanizes its monoclonal antibody Lpathomab

Lipoxen initiates phase I trial of SuliXen for type 1 and type 2 diabetes

Myriad Genetics reports positive results from phase I clinical trial of MPC-0920

Compugen reports in vivo results for two of its drug candidates

Radius launches RAD-1901 clinical program for the treatment of hot flashes

FDA issues complete response letter for Lev Pharmaceuticals' Cinryze

BTG commences first clinical study of novel migraine treatment

Nuvelo commences phase I NU-172 trial

LX-201 granted fast track designation for corneal transplant rejection

EMEA to review GlaxoSmithKline pneumococcal Haemophilus pediatric vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...